Danaher Corporation (DAP.DE)

230,00 -2,65 (-1,14%) Börsenschluss: 05:35PM CEST

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 61.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Steven M. Rales	Co-Founder & Chairman	N/A	N/A	1951
Mr. Rainer M. Blair	President, CEO & Director	4,98M	N/A	1964
Mr. Mitchell P. Rales	Co-Founder & Director	N/A	N/A	1957
Mr. Matthew R. McGrew	CFO & Executive VP	2,4M	N/A	1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Senior VP & Chief Science Officer	1,95M	N/A	1962
Ms. Georgeann F. Couchara	Senior Vice President of Human Resources	1,56M	N/A	1977
Mr. Joakim Weidemanis	Executive Vice President	2,58M	6,08M	1969
Mr. Christopher M. Bouda	VP & Chief Accounting Officer	N/A	N/A	N/A
Mr. John Bedford	Vice President of Investor Relations	N/A	N/A	N/A
Mr. Brian W. Ellis	Senior VP, General Counsel & Chief Compliance Officer	1,81M	N/A	1967

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Corporate Governance

Danaher Corporations ISS Governance QualityScore, Stand 1. April 2024, lautet 7. Die grundlegenden Scores sind Audit: 9, Vorstand: 10, Shareholderrechte: 2, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.